Furosemide Tablet
Product Images NDC 0615-8369

6 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 0615-8369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is An Image Of The Structural Formula For Furosemide. (Furosemide Tabs Usp 20 mg 40 mg 80 mg 8368 8369 83 1)

This Is An Image Of The Structural Formula For Furosemide. (Furosemide Tabs Usp 20 mg 40 mg 80 mg 8368 8369 83 1)
Chemical structure diagram of furosemide showing the molecular arrangement of atoms including chlorine, nitrogen, sulfur, oxygen, and carbon. The molecular formula C12H11ClN2O5S and molecular weight 330.75 are displayed in the image.*
FDA Label Image

Principal Display Panel (Furosemide 20 mg)

Principal Display Panel (Furosemide 20 mg)
Packaging label for Furosemide Tablets USP 20 mg, an oral tablet prescription drug. The label features the drug name, strength, and quantity (30 tablets). It includes multiple barcode sections, lot number 8368, and space for expiration date. The product is labeled for institutional use only and is packaged by Vanguard Labs, Glasgow, KY, for NCS HealthCare of KY, LLC dba Vangard Labs. Storage instructions specify controlled room temperature between 20°-25°C (68°-77°F).*
FDA Label Image

Principal Display Panel (Furosemide 20 mg Unit-Dose)

Principal Display Panel (Furosemide 20 mg Unit-Dose)
Furosemide Tablets USP 20 mg oral tablets label by NCS HealthCare of KY, LLC dba Vangard Labs. The label includes multiple identical barcode panels with the product name, strength, lot number 8368-, and expiration date fields. It also shows a detailed drug label with quantity 30, storage instructions, manufacturer Prinston for Solco, and repackager Vangard Labs, Glasgow, KY 42141.*
FDA Label Image

Principal Display Panel (Furosemide 40 mg)

Principal Display Panel (Furosemide 40 mg)
Label for Furosemide Tablets USP 40 mg, oral tablets, packaged in a quantity of 30. The label includes lot number 8369 and features multiple small sections labeling the product as packaged by Vanguard Labs, Glasgow, KY 42141. Instructions indicate storage at controlled room temperature and protection from light. The label states it is for institutional use only and includes barcodes and manufacturer information for Solco, packaged by Vangard, as well as an Omnicare trademark.*
FDA Label Image

Principal Display Panel (Furosemide 40 mg Unit-Dose)

Principal Display Panel (Furosemide 40 mg Unit-Dose)
Label sheet for Furosemide Tablets USP 40 mg oral tablets featuring multiple barcode labels with the text 'Furosemide Tab USP 40 mg' and space for lot number and expiration date. The packaging is credited to Vangard Labs, Glasgow, KY. A larger main label at the bottom includes quantity (30 tablets), storage instructions, manufacturer and repackager details, and barcode with NDC 43547402130.*
FDA Label Image

Principal Display Panel (Furosemide 80 mg)

Principal Display Panel (Furosemide 80 mg)
Packaging label for Furosemide 80 mg tablets, oral dosage form, with a quantity of 30 tablets. Labeled as Rx only, manufactured by Prinston for Solco and packaged by Vangard Labs, Glasgow, KY 42141. The label includes lot number and expiration date placeholders, barcodes, storage instructions (store at 20°-25°C), and a notice for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.